Post by Kymos Group

▶ 𝐅𝐨𝐫 𝐭𝐡𝐞 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐨𝐟 𝐭𝐨𝐦𝐨𝐫𝐫𝐨𝐰: 𝐉𝐮𝐝𝐢𝐭𝐡 𝐎𝐞𝐭𝐭𝐥 𝐢𝐧 𝐖𝐢𝐫𝐭𝐬𝐜𝐡𝐚𝐟𝐭𝐬𝐟𝐨𝐫𝐮𝐦 Our Business Director in Germany, Judith Oettl, was recently featured in an interview with Wirtschaftsforum, where she shares her perspective on the role of specialized laboratories in today’s drug development landscape. 💬 “Our strength lies in combining deep scientific expertise with the flexibility to support increasingly complex therapies.” In the interview, Judith explains how Kymos Germany (previously Prolytic), as part of Kymos Group, has evolved over the years, expanding from small molecules into biologics and nucleic acid analytics, while maintaining a strong focus on quality and scientific rigor. She also talks about how joining Kymos has strengthened capabilities, improved processes, and enabled more complex projects across an international setting. The conversation gives a clear view of how focused expertise, together with the strength of a broader group, supports the development of new therapies in an increasingly complex environment. 👉 You can read the full interview here (in German):  🔗 https://lnkd.in/e9a4DrQi #Bioanalysis #Biologics #CRO #DrugDevelopment #KymosGroup